Overview

Palatin has a diverse pipeline of active development programs targeting melanocortin and natriuretic receptors in the cardiovascular field, including acute hospital care products for treatment of congestive heart failure, hard-to-control hypertension and for cardiac surgery organ protection, and products for sexual dysfunction, obesity and related metabolic syndrome.